TickerFactsScreenerDevelopers

NORTHWEST BIOTHERAPEUTICS INC (NWBO) — Net Income

Annual figures by fiscal year, from SEC filings.

1997: -$2.56M1998: -$4.72M1999: -$5.61M2000: -$12.78M2001: -$10.94M2002: -$12.80M2003: -$5.75M2004: -$8.51M2005: -$9.94M2006: -$1.40M2007: -$21.25M2008: -$22.33M2009: -$26.95M2010: -$27.37M2011: -$32.83M2012: -$67.32M2013: -$65.79M2014: -$135.63M2015: -$114.74M2016: -$80.21M2017: -$73.14M2018: -$35.79M2019: -$20.81M2020: -$529.82M2021: $179.13M2022: -$105.03M2023: -$62.60M2024: -$83.78M2025: -$60.16M-$60.16M
1997Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$60.16M+28.2%
2024-$83.78M-33.8%
2023-$62.60M+40.4%
2022-$105.03M-158.6%
2021$179.13M+133.8%
2020-$529.82M-2445.7%
2019-$20.81M+41.9%
2018-$35.79M+51.1%
2017-$73.14M+8.8%
2016-$80.21M+30.1%
2015-$114.74M+15.4%
2014-$135.63M-106.2%
2013-$65.79M+2.3%
2012-$67.32M-105.1%
2011-$32.83M-20.0%
2010-$27.37M-1.5%
2009-$26.95M-20.7%
2008-$22.33M-5.1%
2007-$21.25M-1423.1%
2006-$1.40M+86.0%
2005-$9.94M-16.8%
2004-$8.51M-47.9%
2003-$5.75M+55.1%
2002-$12.80M-17.0%
2001-$10.94M+14.4%
2000-$12.78M-127.8%
1999-$5.61M-18.9%
1998-$4.72M-84.3%
1997-$2.56M—